Depression and the Brain's Reward System: When Life Stops Feeling Rewarding
The familiar account is that depression flattens the reward circuit — nothing feels good because the system that registers good has gone quiet. A meta-analysis of 41 whole-brain imaging studies argues against that summary. What it found instead was opposing abnormalities: reduced responses in one region and increased responses in another.
- Coordinate-based meta-analysis of 41 whole-brain studies: 794 people with major depressive disorder and 803 healthy controls (Translational Psychiatry, 2019).
- It argues against the common idea that depression is primarily a deficit within the reward system.
- It found hypo-responses in the ventral striatum and hyper-responses in the orbitofrontal cortex — opposite directions in one circuit.
- A 2026 meta-analysis of 23 studies (1,264 participants) found MDD showed blunted responses only in the bilateral caudate, and only during reward delivery.
Anhedonia is the clinical word for it: things that used to be rewarding stop being rewarding. Not sadness exactly — an absence where anticipation and pleasure used to be. The standard explanation has been that the brain’s reward circuit is running quiet, and it is a satisfying explanation because it maps the symptom directly onto a mechanism. A meta-analysis of the imaging literature suggests that it is too simple, and possibly wrong in an interesting way.
The Standard Account

Many neuroimaging studies have investigated reward-processing dysfunction in major depressive disorder, and they have led to what the meta-analysis calls a common idea: that depression is associated with blunted responses within the reward circuit, particularly in the ventral striatum.
The ventral striatum is a reasonable place to look. It is central to how the brain registers reward and, importantly, how it anticipates one — and anticipation is much of what appears to be missing in anhedonia.
The trouble was that the link between depression and reward-related responses in other regions kept coming back inconclusive, which is a signal that the frame might be wrong rather than merely incomplete.
It is also worth noting how a summary like that becomes standard. Studies that look where previous studies found something tend to find something there too, and a region that acquires a reputation acquires a disproportionate share of the analyses. That is not misconduct; it is how a literature concentrates, and it is a reason to treat a widely repeated summary as a hypothesis rather than a settled result.
What the Meta-Analysis Did
It pooled 41 whole-brain neuroimaging studies of reward-related responses — a total of 794 patients with major depressive disorder and 803 healthy controls — using a coordinate-based method that asks where results converge across studies rather than reanalysing each one (Translational Psychiatry, 2019).
Whole-brain matters here. A study that examines only the ventral striatum can confirm or fail to confirm something about the ventral striatum; it cannot discover that the interesting thing is happening somewhere else.
The Result That Does Not Fit the Summary
The authors state it directly: their findings argue against the common idea that major depressive disorder is primarily linked to deficits within the reward system.
What they found instead was opposing abnormalities inside the same circuit — hypo-responses in the ventral striatum and hyper-responses in the orbitofrontal cortex.
The orbitofrontal cortex is worth a sentence on its own. It is heavily involved in evaluating how much something is worth — comparing options, updating value when circumstances change, deciding whether an outcome met expectation. An increased response there is not obviously a deficit of anything.
Two regions moving in opposite directions is a different kind of finding from one region going quiet. It suggests the problem may be less about how much signal there is and more about the relationship between parts — which is why the authors propose dysregulated corticostriatal connectivity as the underlying account rather than a regional deficit.
A Second Analysis, Narrowing It Further
A 2026 meta-analysis approached reward processing from a different angle: distinguishing bipolar disorder from major depressive disorder, on the grounds that misdiagnosing one as the other delays appropriate treatment. It searched eight databases and identified 23 fMRI studies totalling 1,264 participants (Psychiatry Research: Neuroimaging, 2026).
Its finding for depression was strikingly specific. Major depressive disorder showed blunted responses only in the bilateral caudate, and only during reward delivery — not during anticipation.
Bipolar disorder, by contrast, showed its differences during reward anticipation: hyperactivity in the left inferior frontal gyrus and insula, with reduced activity on the right, and no consistent pattern during delivery.
Anticipation and delivery being separable is the useful part. ‘Reward processing’ is at least two different operations, and a condition can differ on one without differing on the other.
Why This Matters More Than a Technical Correction
Because the simple version has a moral shadow. If the reward system is simply switched off, then motivation is gone and nothing can be done about it from the inside — a framing that lands badly on someone already being told to try harder.
A dysregulated relationship between regions is a different picture. It does not make anything easier, and it is not a reason for optimism about any individual. But it describes a system doing something disordered rather than a system doing nothing, and those are genuinely different claims about what is happening.
It also explains why motivation can be neurologically difficult rather than absent — why the machinery of wanting can be present and still not deliver.
There is a practical version of this too. A model that locates the problem in one structure invites interventions aimed at that structure; a model that locates it in the relationship between structures points somewhere different. Which model is right is an empirical question that is not yet settled, and the honest position is that the field is still arguing.
What Neither Analysis Establishes
Neither is a diagnostic tool. Both are group comparisons pooled across studies, with wide individual variation inside every group. No imaging test for depression exists, and the 2026 paper’s framing as a search for potential biomarkers is a statement of aspiration, not of current practice.
Neither establishes direction. Whether altered reward processing precedes depression, follows from it, or shares a cause with it is not answered by pooling cross-sectional comparisons.
Meta-analysis inherits what it pools. Coordinate-based methods depend on published peaks, which depend on what was reported and what was published — and a literature that expected to find striatal blunting is a literature that reported striatal results.
What both support is narrower: reward processing in depression is measurably atypical, it is regionally specific, it is not a uniform flattening, and anticipation and consumption behave differently. The broader question of whether a system that has learned one pattern can learn another is covered separately.
What the Reward Research Supports — and What It Doesn't
Not a Simple Flattening
A 41-study meta-analysis argues against the standard ‘blunted reward circuit’ account and reports opposing abnormalities instead.
Opposite Directions, One Circuit
Hypo-responses in the ventral striatum alongside hyper-responses in the orbitofrontal cortex, suggesting dysregulated connectivity.
Anticipation Differs From Delivery
A 2026 meta-analysis found MDD blunted only in the bilateral caudate and only during reward delivery.
No Test, No Direction
Group comparisons with wide individual variation. Not diagnostic, and silent on what causes what.

Frequently Asked Questions
Does depression switch off the brain's reward system?
A meta-analysis of 41 whole-brain studies covering 794 patients and 803 controls argues against that account. Rather than a uniform deficit it reported opposing abnormalities — reduced responses in the ventral striatum alongside increased responses in the orbitofrontal cortex — and proposed dysregulated corticostriatal connectivity as a better description.
What is anhedonia?
The reduced capacity to anticipate or experience pleasure from things that were previously rewarding. It is distinguishable from sadness, and much of what people describe concerns anticipation — the wanting — rather than the moment of the reward itself.
Why does it matter whether the problem is anticipation or delivery?
Because they are separable operations, and conditions differ on them differently. A 2026 meta-analysis of 23 studies found major depressive disorder showed blunted responses only in the bilateral caudate and only during reward delivery, while bipolar disorder differed during anticipation instead.
Can a brain scan show whether someone has depression?
No. Every result here is a group-level average pooled across studies, with substantial variation between individuals inside each group. No imaging test for depression exists and none of this research is used diagnostically.
Does this mean motivation cannot be recovered?
Nothing in this research addresses that question, and it would be wrong to read either finding as a statement about prognosis. What the meta-analyses describe is a system behaving atypically rather than a system that is absent — a difference in what is being described, not a prediction about any individual.
Sources
- Meta-analysis of reward processing in major depressive disorder reveals distinct abnormalities within the reward circuit — Translational Psychiatry, November 2019
- Distinct neural signatures of reward processing underlying bipolar disorder and major depressive disorder — Psychiatry Research: Neuroimaging, July 2026
When Motivation Has Become Difficult
Pooled imaging studies describe averages across hundreds of people. Understanding one person means sitting down with that person. NeuroBalance is a small independent practice in Los Angeles — private one-to-one sessions, the same practitioner each visit, in a quiet setting, over fourteen years. A brain health assessment is where that starts.
Schedule Your Free Consultation
Call us: (424) 625-5445 · Los Angeles, CA
Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. LENS Neurofeedback is not FDA-approved for all conditions mentioned. Please consult with a qualified healthcare provider before beginning any new treatment program.
A balanced brain is a better brain for a happier life.